AUVI-Q epinephrine auto-injector temporary supply in Canada

Health Canada announced that they have secured a temporary supply of AUVI-Q® epinephrine auto-injectors from kaléo to help mitigate the…  Read More

AUVI-Q temporary supply FAQs

Please see the FAQs below regarding the AUVI-Q® temporary supply in Canada. These answers were provided by Health Canada and…  Read More

Latest news from Food Allergy Canada – December 2017

Learn more about our upcoming leadership changes, and find out who received our 2017 Robyn Allen Leadership Award for exemplifying extraordinary leadership and dedication in the…  Read More

News: Sanofi to Return Allerject® Rights to kaléo

Sanofi Canada has issued a press release announcing that the License and Development Agreement between Sanofi and kaléo, formerly Intelliject…  Read More

Mise à jour de Sanofi Canada sur le rappel volontaire d’Allerject®

POUR DIFFUSION IMMÉDIATE Laval (Québec) – le 2 décembre 2015 –  À la suite du rappel volontaire effectué par Sanofi-aventis…  Read More

Update by Sanofi Canada on Nationwide Voluntary Recall of Allerject®

FOR IMMEDIATE RELEASE Laval, Quebec – December 2, 2015 – Following the October 28, 2015 voluntary recall by Sanofi-aventis Canada…  Read More

Video: Canadian allergist Dr. Susan Waserman answers questions about the Allerject recall

In this new YouTube video, Canadian allergist Dr. Susan Waserman answers some questions about the Allerject® recall: what happened, what’s…  Read More

Update on the Allerject recall: CSACI statement, EpiPen Availability, FAQs and more

As you may know by now, Sanofi issued a voluntary recall of all Allerject products earlier this week. Food Allergy…  Read More

National voluntary recall of Allerject® products

Sanofi-aventis Canada Inc. has issued a voluntary recall of all Allerject® products, including both the 0.15 mg/0.15 mL and 0.3…  Read More